AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34744069 — intervention group
Group type: COMPARATOR
Intervention: Gym Ball Exercises (GBE)
Number of subjects: 40
Study 33258518 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurology ultrasound workshop (n = 57)
Number of subjects: 360
Study 33258518 — intervention group
Group type: COMPARATOR
Intervention: Traditional curriculum control group
Number of subjects: 360
Study 34920046 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 42010
Study 34920046 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose TXA (≥50 mg/kg)
Number of subjects: 42010
Study 34772753 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fixation device
Number of subjects: 120
Study 34772753 — intervention group
Group type: COMPARATOR
Intervention: Conventional fixation
Number of subjects: 120
Study 36409542 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-day self-guided body image and self-compassion mHealth app (n=149)
Number of subjects: 310
Study 36409542 — intervention group
Group type: COMPARATOR
Intervention: Active waitlist control group (n=161)
Number of subjects: 310
Study 36409542 — intervention group
Group type: COMPARATOR
Intervention: Both apps (mHealth app and active waitlist control)
Number of subjects: 310
Study 33176306 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric care (CGC) delivered by a geriatrician, physiotherapist, and occupational therapist.
Number of subjects: 53
Study 33176306 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 53
Study 34599603 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended early intervention
Number of subjects: 220
Study 34599603 — intervention group
Group type: COMPARATOR
Intervention: Regular care
Number of subjects: 220
Study 33631007 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet flavored NVPs
Number of subjects: 886
Study 33631007 — intervention group
Group type: COMPARATOR
Intervention: Tobacco flavored NVPs
Number of subjects: 886
Study 33631007 — intervention group
Group type: COMPARATOR
Intervention: Menthol flavored NVPs
Number of subjects: 886
Study 33631007 — intervention group
Group type: EXPERIMENTAL
Intervention: Vapers who quit smoking in 2018
Number of subjects: 886
Study 33631007 — intervention group
Group type: COMPARATOR
Intervention: Continuing smokers in 2018
Number of subjects: 886
Study 32902321 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous IgG (IVIG) treatment
Number of subjects: 80
Study 32902321 — intervention group
Group type: COMPARATOR
Intervention: Untreated group (Control)
Number of subjects: 80
Study 33737614 — intervention group
Group type: COMPARATOR
Intervention: 350 g/kg iso-lipid test diet
Number of subjects: 450
Study 33737614 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 g/kg iso-lipid test diet
Number of subjects: 450
Study 33737614 — intervention group
Group type: EXPERIMENTAL
Intervention: 450 g/kg iso-lipid test diet
Number of subjects: 450
Study 33737614 — intervention group
Group type: EXPERIMENTAL
Intervention: 550 g/kg iso-lipid test diet
Number of subjects: 450
Study 33737614 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 g/kg iso-lipid test diet
Number of subjects: 450
Study 33737614 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimum protein level
Number of subjects: 450
Study 32620339 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (APAP) 3 g/d for 28 days
Number of subjects: 242
Study 32620339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study 34513873 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglactin 10-0 sutures
Number of subjects: 80
Study 34513873 — intervention group
Group type: COMPARATOR
Intervention: Nylon 10-0 sutures
Number of subjects: 80
Study 32247559 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (400 units/day)
Number of subjects: 81
Study 32247559 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg/day)
Number of subjects: 81
Study 32247559 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E + C
Number of subjects: 81
Study 32247559 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 81
Study 35321588 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial shortening
Number of subjects: 52
Study 35321588 — intervention group
Group type: COMPARATOR
Intervention: Capitate shortening
Number of subjects: 52
Study 33523031 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorineural hearing loss group
Number of subjects: 200
Study 33523031 — intervention group
Group type: COMPARATOR
Intervention: Control group (normative values according to the scale)
Number of subjects: 200
Study 34709684 — intervention group
Group type: EXPERIMENTAL
Intervention: THN102 200/2 (200 mg/d modafinil with 2 mg/d flecainide)
Number of subjects: 75
Study 34709684 — intervention group
Group type: EXPERIMENTAL
Intervention: THN102 200/18 (200 mg/d modafinil with 18 mg/d flecainide)
Number of subjects: 75
Study 34709684 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 32990504 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (laser therapy over acupuncture points, λ=786.94 nm, 20 sec per point, fluency=33.5 Jcm2, energy=1 J, number of points=12)
Number of subjects: 76
Study 32990504 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal splint (OS) therapy
Number of subjects: 76
Study 32990504 — intervention group
Group type: COMPARATOR
Intervention: Sham laser therapy
Number of subjects: 76
Study 32990504 — intervention group
Group type: COMPARATOR
Intervention: Control group without SB
Number of subjects: 76
Study 32881842 — intervention group
Group type: COMPARATOR
Intervention: Informed of the load (control group, n = 10)
Number of subjects: 20
Study 32881842 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninformed (blinded group, n = 10)
Number of subjects: 20
Study 32881842 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (60% and 80% 1RM protocols)
Number of subjects: 20
Study 35888678 — intervention group
Group type: EXPERIMENTAL
Intervention: Online learning (Group O)
Number of subjects: 32
Study 35888678 — intervention group
Group type: COMPARATOR
Intervention: Hands-on learning (Group H)
Number of subjects: 32
Study 35888678 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study 33190513 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Foes condition
Number of subjects: 0
Study 33190513 — intervention group
Group type: COMPARATOR
Intervention: Fast Friends condition
Number of subjects: 0
Study 35106970 — intervention group
Group type: EXPERIMENTAL
Intervention: School-linked text message intervention
Number of subjects: 26
Study 33401161 — intervention group
Group type: EXPERIMENTAL
Intervention: Playing conventional board games with traditional number dice (dot faces numbered from one to six)
Number of subjects: 30
Study 33401161 — intervention group
Group type: COMPARATOR
Intervention: Playing board games with color or non-numerical symbol dice
Number of subjects: 30
Study 33401161 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up test 1 year after the intervention
Number of subjects: 30
Study 33693315 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpregnancy family planning interventions focusing on quality FP counseling and service provision prior to discharge.
Number of subjects: 8796
Study 33693315 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 8796
Study 33693315 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 8796
Study 34753522 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Support intervention (PSG)
Number of subjects: 31
Study 34753522 — intervention group
Group type: COMPARATOR
Intervention: Minimal Support intervention (MSG)
Number of subjects: 31
Study 33704056 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum endocan levels in RHD group
Number of subjects: 29
Study 33704056 — intervention group
Group type: COMPARATOR
Intervention: Serum endocan levels in control group
Number of subjects: 29
Study 33704056 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary endocan levels in RHD group
Number of subjects: 29
Study 33704056 — intervention group
Group type: COMPARATOR
Intervention: Urinary endocan levels in control group
Number of subjects: 29
Study 33704056 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of serum endocan level with uric acid level in RHD group
Number of subjects: 29
Study 34191081 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg perampanel
Number of subjects: 66
Study 34191081 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg perampanel
Number of subjects: 66
Study 34191081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 33773395 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive body frame with idealized models
Number of subjects: 568
Study 33773395 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive body frame
Number of subjects: 568
Study 33773395 — intervention group
Group type: COMPARATOR
Intervention: Active body frame
Number of subjects: 568
Study 33773395 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-idealized models
Number of subjects: 568
Study 32444220 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous umbilical cord blood infusion
Number of subjects: 180
Study 32444220 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic umbilical cord blood infusion
Number of subjects: 180
Study 32444220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 35579006 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) at 33°C
Number of subjects: 0
Study 35579006 — intervention group
Group type: COMPARATOR
Intervention: Fever control alone
Number of subjects: 0
Study 34287251 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp cooling application
Number of subjects: 74
Study 34287251 — intervention group
Group type: COMPARATOR
Intervention: Traditional chemotherapy setting
Number of subjects: 74
Study 34287251 — intervention group
Group type: COMPARATOR
Intervention: No scalp cooling application
Number of subjects: 74
Study 35853600 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance feedback intervention (introductory training module, weekly electronic 'Quick Tips', and 3 individualized performance feedback reports)
Number of subjects: 48
Study 35853600 — intervention group
Group type: COMPARATOR
Intervention: Control group (no performance feedback)
Number of subjects: 48
Study 33605397 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% Nitrous oxide (N2O) administered for 60 minutes twice a week for 4 weeks.
Number of subjects: 23
Study 33605397 — intervention group
Group type: COMPARATOR
Intervention: Placebo (100% oxygen) administered for 60 minutes twice a week for 4 weeks.
Number of subjects: 23
Study 35230058 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) - 5 consecutive daily 90-minute sessions at 2.0 atmospheres absolute with 100% oxygen
Number of subjects: 31
Study 35230058 — intervention group
Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 31
Study 35230058 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 31
Study 32167863 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib 20 mg once daily plus Pembrolizumab 200 mg intravenously once every 3 weeks
Number of subjects: 108
Study 32167863 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib plus Pembrolizumab
Number of subjects: 108
Study 33179515 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral combined estradiol (E2) and progesterone therapy
Number of subjects: 1173
Study 32005747 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant capecitabine
Number of subjects: 111
Study 34713713 — intervention group
Group type: EXPERIMENTAL
Intervention: Red meat diet
Number of subjects: 0
Study 34713713 — intervention group
Group type: EXPERIMENTAL
Intervention: White meat diet
Number of subjects: 0
Study 34713713 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-meat diet
Number of subjects: 0
Study 34713713 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal culture measuring choline- and carnitine-trimethylamine lyase activity
Number of subjects: 0
Study 33162830 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine biomarkers (CCL27, IFN‐γ, IL‐4)
Number of subjects: 0
Study 33162830 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine biomarkers (serum)
Number of subjects: 0
Study 33162830 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine biomarkers (CSF)
Number of subjects: 0
Study 35277071 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose iron and curcumin (FS65_Curc)
Number of subjects: 155
Study 35277071 — intervention group
Group type: COMPARATOR
Intervention: High dose iron and curcumin placebo (FS65_Plac)
Number of subjects: 155
Study 35277071 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose iron and curcumin (FS18_Curc)
Number of subjects: 155
Study 35277071 — intervention group
Group type: COMPARATOR
Intervention: Low dose iron and curcumin placebo (FS18_Plac)
Number of subjects: 155
Study 35277071 — intervention group
Group type: COMPARATOR
Intervention: Iron and curcumin placebo (FS0_Plac)
Number of subjects: 155
Study 33864725 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral allopurinol 300 mg twice daily
Number of subjects: 60
Study 33864725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35141805 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial ultrasound stimulation (TUS) combined with conventional cognitive rehabilitation training
Number of subjects: 60
Study 35141805 — intervention group
Group type: COMPARATOR
Intervention: Conventional cognitive rehabilitation training and sham-TUS stimulation
Number of subjects: 60
Study 33798310 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture therapy (regulating menstruation and promoting pregnancy) at Baihui (GV 20), Shenting (GV 24), Guanyuan (CV 4), Sanyinjiao (SP 6), Shenshu (BL 23), Ciliao (BL 32), once a day, 5 times a week for 3 months.
Number of subjects: 60
Study 33798310 — intervention group
Group type: COMPARATOR
Intervention: Western medication (oral administration of climen, 1 tablet a day for 21 days, stopped for 1 week as a course, required 3 consecutive courses).
Number of subjects: 60
Study 34478879 — intervention group
Group type: EXPERIMENTAL
Intervention: Skipping breakfast ≥ 3 days/week (n = 102)
Number of subjects: 602
Study 34478879 — intervention group
Group type: EXPERIMENTAL
Intervention: Skipping lunch ≥ 3 days/week
Number of subjects: 602
Study 34478879 — intervention group
Group type: EXPERIMENTAL
Intervention: Skipping dinner ≥ 1 day/week
Number of subjects: 602
Study 34478879 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonstandard shifts
Number of subjects: 602
Study 34478879 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal skipping
Number of subjects: 602
Study 33528744 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweets without misinformation
Number of subjects: 1206
Study 33528744 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweets from organizations
Number of subjects: 1206
Study 33528744 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweets about effectiveness
Number of subjects: 1206
Study 33528744 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweets with misinformation
Number of subjects: 1206
Study 35576620 — intervention group
Group type: EXPERIMENTAL
Intervention: Training provided by healthcare professional
Number of subjects: 22
Study 35576620 — intervention group
Group type: COMPARATOR
Intervention: Training provided by caregivers
Number of subjects: 22
Study 34962984 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypill
Number of subjects: 0
Study 34962984 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypill plus aspirin
Number of subjects: 0
Study 32908704 — intervention group
Group type: EXPERIMENTAL
Intervention: Completion of continuum of maternal healthcare services
Number of subjects: 565
Study 32908704 — intervention group
Group type: EXPERIMENTAL
Intervention: Ability to read and write
Number of subjects: 565
Study 32908704 — intervention group
Group type: EXPERIMENTAL
Intervention: Using car/motorcycle as a means of transportation
Number of subjects: 565
Study 32908704 — intervention group
Group type: EXPERIMENTAL
Intervention: Travel time less than an hour to health facility
Number of subjects: 565
Study 32908704 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with service delivery
Number of subjects: 565
Study 32908704 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiving health education on maternal healthcare services in the last 6 months
Number of subjects: 565
Study 34234209 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 361194
Study 34234209 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking initiation (positive control)
Number of subjects: 361194
Study 34234209 — intervention group
Group type: COMPARATOR
Intervention: Absorbate (negative control)
Number of subjects: 361194
Study 35184667 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-delivered auditory training with live-voice conversations in the presence of a single-talker distractor (30 min/day, 5 days/week over 4 weeks)
Number of subjects: 39
Study 35184667 — intervention group
Group type: COMPARATOR
Intervention: Home-delivered auditory training with live-voice conversations in quiet (active-control group)
Number of subjects: 39
Study 35184667 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-delivered auditory training with live-voice conversations in the presence of a single-talker distractor
Number of subjects: 39
Study 34429152 — intervention group
Group type: EXPERIMENTAL
Intervention: Peficitinib 100 mg
Number of subjects: 1025
Study 34429152 — intervention group
Group type: EXPERIMENTAL
Intervention: Peficitinib 150 mg
Number of subjects: 1025
Study 34429152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1025
Study 32207416 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer debriefing using Pendleton's method (Group B)
Number of subjects: 84
Study 32207416 — intervention group
Group type: COMPARATOR
Intervention: Facilitator-led demonstration (Group A)
Number of subjects: 84
Study 34787762 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional periodontal treatment associated with 10 laser applications by the ILIB‐Modified (ILIB‐M) technique
Number of subjects: 21
Study 34787762 — intervention group
Group type: COMPARATOR
Intervention: Conventional periodontal therapy
Number of subjects: 21
Study 33011964 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 3275
Study 33011964 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (all patients from AVERROES to open-label extension)
Number of subjects: 3275
Study 32532654 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramelteon (8 mg)
Number of subjects: 80
Study 32532654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 35772622 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial Photodynamic Therapy (aPDT) with 300 µmol/L of methylene blue
Number of subjects: 108
Study 35772622 — intervention group
Group type: COMPARATOR
Intervention: Antimicrobial Photodynamic Therapy (aPDT) with 8 µmol/L of curcumin
Number of subjects: 108
Study 35387778 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear lens extraction (CLE)
Number of subjects: 369
Study 35387778 — intervention group
Group type: COMPARATOR
Intervention: Laser peripheral iridotomy (LPI)
Number of subjects: 369
Study 33592830 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet group (group 1)
Number of subjects: 20
Study 33592830 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet free group (group 2)
Number of subjects: 20
Study 34565261 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet
Number of subjects: 0
Study 34565261 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 0
Study 32753699 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG antibodies against non-self glycans
Number of subjects: 27
Study 32753699 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG antibodies against self glycans
Number of subjects: 27
Study 32753699 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-self glycan IgG antibodies with simultaneous IgM presence
Number of subjects: 27
Study 32753699 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-self glycan A subgroup (GM2/GM1/GD1b)
Number of subjects: 27
Study 32753699 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-self glycan B subgroup (GM3/GD1a/GD3/GT1b/GQ1b)
Number of subjects: 27
Study 35623863 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziziphus jujube (30 g daily for 12 weeks)
Number of subjects: 48
Study 34526918 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied over the left prefrontal cortex during social cognition training for 10 sessions within 2 consecutive weeks.
Number of subjects: 20
Study 34526918 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS applied over the left prefrontal cortex during social cognition training for 10 sessions within 2 consecutive weeks.
Number of subjects: 20
Study 34526918 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up assessments 1 and 6 months after the intervention.
Number of subjects: 20
Study 34526918 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolerability evaluated using a standardized questionnaire.
Number of subjects: 20
Study 34704516 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS)
Number of subjects: 66
Study 34704516 — intervention group
Group type: COMPARATOR
Intervention: Copper intrauterine device (Cu-IUD)
Number of subjects: 66
Study 34807658 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based online intervention (ORBIT 2.0)
Number of subjects: 302
Study 34807658 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation control
Number of subjects: 302
Study 33049054 — intervention group
Group type: EXPERIMENTAL
Intervention: Midostaurin
Number of subjects: 163
Study 33049054 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study 33049054 — intervention group
Group type: EXPERIMENTAL
Intervention: NPM1mut/FLT3-TKDmut or CBF-rearranged/FLT3-TKDmut
Number of subjects: 163
Study 35168657 — intervention group
Group type: EXPERIMENTAL
Intervention: Casper + spreader group
Number of subjects: 94
Study 35168657 — intervention group
Group type: COMPARATOR
Intervention: Casper alone group
Number of subjects: 94